Alzheimer's Disease Diagnostics & Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025

Description

Persistence Market Research has recently released a comprehensive report on the global Alzheimer's Disease Diagnostics & Treatment Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Alzheimer's Disease Diagnostics & Treatment Market Size (2025E): US$7.3 Bn
Projected Market Value (2032F): US$13.3 Bn
Global Market Growth Rate (CAGR 2025 to 2032): 9.0%

Alzheimer's Disease Diagnostics & Treatment Market - Report Scope:

The global Alzheimer's disease diagnostics and treatment market is growing due to the increasing prevalence of neurodegenerative diseases, especially in aging populations. The market includes a range of diagnostic technologies, such as neuroimaging, cognitive tests, and biomarkers, alongside treatments aimed at managing symptoms and progressing toward disease-modifying therapies. Technological advancements, increased awareness, and growing investments in research are key drivers contributing to the expansion of this market. The rising global population of elderly individuals significantly impacts the demand for better diagnostic solutions and therapeutic treatments.

Market Drivers:

The growth of the Alzheimer's disease diagnostics and treatment market is primarily driven by the profound consequences of the world's aging population. The substantial rise in the elderly demographic, especially in developed regions, has resulted in a higher incidence of Alzheimer's disease. With aging comes an increase in neurodegenerative diseases, particularly Alzheimer's, which necessitates advanced diagnostic tools and effective therapies. As life expectancy increases globally, so does the demand for timely and accurate diagnostics, alongside innovative treatments. Furthermore, technological advances in neuroimaging, including PET and fMRI, play a vital role in enabling early detection and better management of the disease. A shift in societal attitudes toward mental health and greater awareness of Alzheimer's have contributed to increased diagnoses, propelling market growth.

Market Restraints:

Despite the positive growth trajectory, the Alzheimer's disease diagnostics and treatment market faces significant challenges, including regulatory obstacles and stringent approval processes. The complexity of neurological disorders requires a meticulous examination by regulatory bodies, which can result in long development times and high costs. Additionally, the market grapples with restricted reimbursement policies, which create barriers to access for patients and limit the widespread implementation of advanced diagnostic tools and treatments. As these diagnostic tools and treatments often require substantial financial investment, the lack of comprehensive reimbursement policies can further hinder market expansion.

Market Opportunities:

There are considerable opportunities within the Alzheimer's disease diagnostics and treatment market driven by accelerating technological progress. Advancements in neuroimaging technologies, such as PET scans and fMRI, provide unprecedented opportunities for early and accurate diagnosis. The incorporation of artificial intelligence (AI) and machine learning in analyzing complex datasets has the potential to identify new biomarkers, enhancing diagnostic precision. Moreover, the rise of digital health platforms and telemedicine offers innovative solutions for personalized care, enabling remote monitoring and improving accessibility for patients. These advancements create opportunities for a more effective and scalable approach to Alzheimer's care, while also offering avenues for cost reductions in healthcare systems.

Key Questions Answered in the Report:

What are the primary factors driving the global growth of the Alzheimer's disease diagnostics and treatment market?
How are advancements in neuroimaging and diagnostic technologies shaping the market?
What are the key therapeutic developments in the Alzheimer's disease treatment pipeline?
Who are the key players in the Alzheimer's disease diagnostics and treatment market, and what strategies are they employing to maintain their market positions?
What are the emerging trends and future outlooks for the Alzheimer's disease diagnostics and treatment market?

Competitive Intelligence and Business Strategy:

Leading companies in the Alzheimer's disease diagnostics and treatment market are focusing on innovations in diagnostic technologies, drug development, and personalized care solutions to maintain a competitive edge. Companies are heavily investing in research and development (R&D) to advance disease-modifying therapies and adopt cutting-edge technologies like AI, to enable earlier detection and more efficient treatment monitoring. Strategic collaborations between pharmaceutical companies, biotech firms, and research institutions are key to driving innovation in this space. Furthermore, businesses are expanding their product portfolios to meet the growing demand for advanced diagnostic tools and personalized treatments for Alzheimer's.

Key Companies Profiled:

Biogen Inc.
AbbVie, Inc.
Teva Pharmaceuticals Ltd.
Eisai Co.Ltd.
Janssen Pharmaceuticals Inc.
Novartis AG
Zydus Lifesciences Ltd.
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Aurobindo Pharma Ltd.

Alzheimer's Disease Diagnostics & Treatment Market Segmentation:

By Product:

Therapeutics
Diagnostics

By Distribution Channel:

Institutional Sales
Retail Sales

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33700

1. Executive Summary

1.1. Global Alzheimer Disease Diagnostics & Treatment Market Snapshot, 2025 - 2032
1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Alzheimer Disease Diagnostics & Treatment Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Bn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2019 - 2023
- 3.2.2. Current Market Size Forecast, 2025 - 2032
3.3. Global Alzheimer Disease Diagnostics & Treatment Market Outlook: Product
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019 - 2023
- 3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
  - 3.3.3.1. Therapeutics
    - 3.3.3.1.1. Cholinesterase Inhibitors
    - 3.3.3.1.2. NMDA Receptor Antagonists
    - 3.3.3.1.3. Manufactured Combination
  - 3.3.3.2. Diagnostics
    - 3.3.3.2.1. Lumbar Diagnostics Test
    - 3.3.3.2.2. CT Scan
    - 3.3.3.2.3. MRI
    - 3.3.3.2.4. EEG
    - 3.3.3.2.5. PET scan
3.4. Market Attractiveness Analysis: Product
3.5. Global Alzheimer Disease Diagnostics & Treatment Market Outlook: Distribution Channel
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
- 3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  - 3.5.3.1. Institutional Sales
    - 3.5.3.1.1. Hospitals
    - 3.5.3.1.2. Specialty Clinics
    - 3.5.3.1.3. Diagnostic Centers
  - 3.5.3.2. Retail Sales
    - 3.5.3.2.1. Retail Pharmacies
    - 3.5.3.2.2. Drug Stores
    - 3.5.3.2.3. Online Pharmacies
3.6. Market Attractiveness Analysis: Distribution Channel

4. Global Alzheimer Disease Diagnostics & Treatment Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019 - 2023
4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2025 - 2032
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
- 5.3.1. By Country
- 5.3.2. By Product
- 5.3.3. By Distribution Channel
5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
- 5.5.1. Therapeutics
  - 5.5.1.1. Cholinesterase Inhibitors
  - 5.5.1.2. NMDA Receptor Antagonists
  - 5.5.1.3. Manufactured Combination
- 5.5.2. Diagnostics
  - 5.5.2.1. Lumbar Diagnostics Test
  - 5.5.2.2. CT Scan
  - 5.5.2.3. MRI
  - 5.5.2.4. EEG
  - 5.5.2.5. PET scan
5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
- 5.6.1. Institutional Sales
  - 5.6.1.1. Hospitals
  - 5.6.1.2. Specialty Clinics
  - 5.6.1.3. Diagnostic Centers
- 5.6.2. Retail Sales
  - 5.6.2.1. Retail Pharmacies
  - 5.6.2.2. Drug Stores
  - 5.6.2.3. Online Pharmacies
5.7. Market Attractiveness Analysis

6. Europe Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
- 6.3.1. By Country
- 6.3.2. By Product
- 6.3.3. By Distribution Channel
6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkey
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
- 6.5.1. Therapeutics
  - 6.5.1.1. Cholinesterase Inhibitors
  - 6.5.1.2. NMDA Receptor Antagonists
  - 6.5.1.3. Manufactured Combination
- 6.5.2. Diagnostics
  - 6.5.2.1. Lumbar Diagnostics Test
  - 6.5.2.2. CT Scan
  - 6.5.2.3. MRI
  - 6.5.2.4. EEG
  - 6.5.2.5. PET scan
6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
- 6.6.1. Institutional Sales
  - 6.6.1.1. Hospitals
  - 6.6.1.2. Specialty Clinics
  - 6.6.1.3. Diagnostic Centers
- 6.6.2. Retail Sales
  - 6.6.2.1. Retail Pharmacies
  - 6.6.2.2. Drug Stores
  - 6.6.2.3. Online Pharmacies
6.7. Market Attractiveness Analysis

7. East Asia Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
- 7.3.1. By Country
- 7.3.2. By Product
- 7.3.3. By Distribution Channel
7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
- 7.5.1. Therapeutics
  - 7.5.1.1. Cholinesterase Inhibitors
  - 7.5.1.2. NMDA Receptor Antagonists
  - 7.5.1.3. Manufactured Combination
- 7.5.2. Diagnostics
  - 7.5.2.1. Lumbar Diagnostics Test
  - 7.5.2.2. CT Scan
  - 7.5.2.3. MRI
  - 7.5.2.4. EEG
  - 7.5.2.5. PET scan
7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
- 7.6.1. Institutional Sales
  - 7.6.1.1. Hospitals
  - 7.6.1.2. Specialty Clinics
  - 7.6.1.3. Diagnostic Centers
- 7.6.2. Retail Sales
  - 7.6.2.1. Retail Pharmacies
  - 7.6.2.2. Drug Stores
  - 7.6.2.3. Online Pharmacies
7.7. Market Attractiveness Analysis

8. South Asia & Oceania Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
- 8.3.1. By Country
- 8.3.2. By Product
- 8.3.3. By Distribution Channel
8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
- 8.5.1. Therapeutics
  - 8.5.1.1. Cholinesterase Inhibitors
  - 8.5.1.2. NMDA Receptor Antagonists
  - 8.5.1.3. Manufactured Combination
- 8.5.2. Diagnostics
  - 8.5.2.1. Lumbar Diagnostics Test
  - 8.5.2.2. CT Scan
  - 8.5.2.3. MRI
  - 8.5.2.4. EEG
  - 8.5.2.5. PET scan
8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
- 8.6.1. Institutional Sales
  - 8.6.1.1. Hospitals
  - 8.6.1.2. Specialty Clinics
  - 8.6.1.3. Diagnostic Centers
- 8.6.2. Retail Sales
  - 8.6.2.1. Retail Pharmacies
  - 8.6.2.2. Drug Stores
  - 8.6.2.3. Online Pharmacies
8.7. Market Attractiveness Analysis

9. Latin America Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
- 9.3.1. By Country
- 9.3.2. By Product
- 9.3.3. By Distribution Channel
9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
- 9.5.1. Therapeutics
  - 9.5.1.1. Cholinesterase Inhibitors
  - 9.5.1.2. NMDA Receptor Antagonists
  - 9.5.1.3. Manufactured Combination
- 9.5.2. Diagnostics
  - 9.5.2.1. Lumbar Diagnostics Test
  - 9.5.2.2. CT Scan
  - 9.5.2.3. MRI
  - 9.5.2.4. EEG
  - 9.5.2.5. PET scan
9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
- 9.6.1. Institutional Sales
  - 9.6.1.1. Hospitals
  - 9.6.1.2. Specialty Clinics
  - 9.6.1.3. Diagnostic Centers
- 9.6.2. Retail Sales
  - 9.6.2.1. Retail Pharmacies
  - 9.6.2.2. Drug Stores
  - 9.6.2.3. Online Pharmacies
9.7. Market Attractiveness Analysis

10. Middle East & Africa Alzheimer Disease Diagnostics & Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
- 10.3.1. By Country
- 10.3.2. By Product
- 10.3.3. By Distribution Channel
10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
- 10.5.1. Therapeutics
  - 10.5.1.1. Cholinesterase Inhibitors
  - 10.5.1.2. NMDA Receptor Antagonists
  - 10.5.1.3. Manufactured Combination
- 10.5.2. Diagnostics
  - 10.5.2.1. Lumbar Diagnostics Test
  - 10.5.2.2. CT Scan
  - 10.5.2.3. MRI
  - 10.5.2.4. EEG
  - 10.5.2.5. PET scan
10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
- 10.6.1. Institutional Sales
  - 10.6.1.1. Hospitals
  - 10.6.1.2. Specialty Clinics
  - 10.6.1.3. Diagnostic Centers
- 10.6.2. Retail Sales
  - 10.6.2.1. Retail Pharmacies
  - 10.6.2.2. Drug Stores
  - 10.6.2.3. Online Pharmacies
10.7. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2024
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Biogen Inc.
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. AbbVie, Inc.
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Teva Pharmaceuticals Ltd.
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Eisai Co.Ltd.
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Janssen Pharmaceuticals Inc.
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Novartis AG
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Zydus Lifesciences Ltd.
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Sun Pharmaceutical Industries Ltd.
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Dr. Reddy's Laboratories Ltd.
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. Aurobindo Pharma Ltd.
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations

Alzheimer's Disease Diagnostics & Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032